Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Roundhill GLP-1 & Weight Loss ETF (NQ: OZEM )

26.85 +0.08 (+0.30%)
Official Closing Price Updated: 4:15 PM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 40,127
Open 26.93
Bid (Size) 26.26 (1)
Ask (Size) 28.00 (11)
Prev. Close 26.77
Today's Range 26.77 - 27.11
52wk Range 24.51 - 28.66
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry. 
Via Benzinga
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential
New ETFs focusing on weight-loss drugs have launched. However, industry observers caution about their long-term prospects and the concentrated risks associated with these investments. 
Via Benzinga
Topics ETFs

Performance

YTD
+5.83%
+5.83%
1 Month
+3.63%
+3.63%
3 Month
+5.83%
+5.83%
6 Month
+5.83%
+5.83%
1 Year
+5.83%
+5.83%

More News

Read More
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk
Via Benzinga
Topics ETFs
Tesla (TSLA) Stock Drops as Glass Lewis Urges Against Elon Musk’s Pay Package
Via InvestorPlace
Campbell Soup Layoffs 2024: What to Know About New Campbell Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF
Via InvestorPlace
Topics ETFs
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
Via Benzinga
Topics ETFs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.